NAA Associated Epilepsy

Epilepsy is a kind of chronic NAA-related neurological disease. Based on our extensive experience and highly specialized equipment, Creative Biolabs has made great achievements in both NAA researches and related diseases studies. We are proud to provide clients with our profound expertise, the best and professional solutions, and NAA services on epilepsy.

What Is Epilepsy?

Epilepsy is a group of chronic, neurological disorders characterized by recurrent, unprovoked seizures. Epileptic seizures actually are a pattern of abnormal brain activity causing periods of unusual behavior, sensations, and sometimes loss of awareness.

➢ Symptoms and Signs

Recurrent seizures are the main symptoms of epilepsy. Seizures can also affect other processes in brain leading to a variety of symptoms:

➢ Causes and Pathogenesis

Genes, physical and environmental factors like tumors, strokes, misuse of drugs, malnutrition, and dysimmunity all are capable be the causes of seizures or epilepsy. Pathogenesis and the exact mechanism of epilepsy are still remain unclear.

Fig.1 Brain anatomical changes in epilepsy. (Vinti, et al., 2021)Fig.1 Symptoms of epilepsy.1

Diagnosis and Treatment of Epilepsy

Epilepsy diagnosis seems to be difficult as there are many other conditions presenting very similar signs and symptoms to seizures. Symptom observation, electroencephalogram, neuroimaging like CT or MRI scan, and blood tests can help a doctor to diagnose epilepsy.

The Importance of NAA in Epilepsy

Like other neurological diseases, current treatment can’t cure most types of epilepsy. Daily medication such as anti-epileptic drugs or anti-convulsant drugs usually is the first choice. Epilepsy surgery may be a better option for patients with focal seizures. In recent years, natural autoantibodies associated with epilepsy have been researched for the sake of new diagnosis and treatment. Most autoantibodies relevant to epilepsy are directed targets to molecules as voltage-gated potassium channel (VGKC) complex, glutamic acid decarboxylase, Glutamate receptor 3 (GluR3). Autoantibodies against these molecules may be a potential therapy for epilepsy. Autoantibodies associated with epilepsy by Creative Biolabs including but not limited to the followings:


MS analysis reveals that histones are a likely target of autoantibodies in the brain from patients with epilepsy. Fig.2 MS analysis reveals that histones are likely targets of autoantibodies in the brain from patients with epilepsy. (Iffland, 2013)

Creative Biolabs has extensive experience, a full range of technology platform, and Ph.D. level scientists to provide high-quality NAA detection and analysis service. We have successfully developed several effective strategies in epilepsy and related NAA biomarkers research. If you need a professional scientific research staff and a full range of NAA services, just feel free to contact us for more detailed information.

References

  1. Vinti, Valerio, et al. "Temporal lobe epilepsy and psychiatric comorbidity." Frontiers in neurology 12 (2021): 775781.
  2. Iffland II, Philip H., et al. "Intracellular and circulating neuronal antinuclear antibodies in human epilepsy." Neurobiology of disease 59 (2013): 206-219.

Choosing natural autoantibody (NAA) microarray to profile autoantibody repertoire and reveal novel disease's marker.

For Research Use Only | Not For Clinical Use

Related Services:

Products:

Resource:

Applications:

Online Inquiry
Inquiry